You are here

Article info

Article menu
XML
Inflammatory bowel disease
Original article
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation

Authors

  • Toshihiro Matsukawa Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kumi Izawa Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Masamichi Isobe Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Mariko Takahashi Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Akie Maehara Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Yoshinori Yamanishi Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Ayako Kaitani Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Ko Okumura Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Takanori Teshima Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan PubMed articlesGoogle scholar articles
  • Toshio Kitamura Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Division of Stem Cell Signaling, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Jiro Kitaura Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Toshio Kitamura, Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan; kitamura@ims.u-tokyo.ac.jp and Dr Jiro Kitaura, Atopy Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; kitaura-tky{at}umin.ac.jp
View Full Text

Citation

Matsukawa T, Izawa K, Isobe M, et al
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation
Gut 2016;65:777-787.

Publication history

  • Received November 26, 2014
  • Revised January 11, 2015
  • Accepted January 17, 2015
  • First published February 11, 2015.
Online issue publication 
October 26, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/